Fairmount Funds Management as of Dec. 31, 2023
Portfolio Holdings for Fairmount Funds Management
Fairmount Funds Management holds 16 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Axsome Therapeutics (AXSM) | 19.8 | $188M | 2.4M | 79.59 | |
| ImmunoGen | 18.6 | $176M | 5.9M | 29.65 | |
| Nuvalent Inc-a (NUVL) | 15.0 | $142M | 1.9M | 73.59 | |
| Apogee Therapeutics (APGE) | 8.7 | $82M | 2.9M | 27.94 | |
| Rayzebio | 8.2 | $78M | 1.2M | 62.17 | |
| Kiniksa Pharmaceuticals Com Cl A | 5.3 | $51M | 2.9M | 17.54 | |
| Argenx Se Sponsored Adr (ARGX) | 4.5 | $43M | 113k | 380.43 | |
| Miragen Therapeutics (VRDN) | 3.2 | $30M | 1.4M | 21.78 | |
| Enliven Therapeutics (ELVN) | 3.1 | $30M | 2.1M | 13.84 | |
| Astria Therapeutics (ATXS) | 2.9 | $27M | 3.6M | 7.68 | |
| Cogent Biosciences (COGT) | 2.2 | $21M | 3.6M | 5.88 | |
| Dianthus Therapeutics (DNTH) | 2.1 | $20M | 1.9M | 10.40 | |
| Merus N V (MRUS) | 2.1 | $20M | 717k | 27.50 | |
| Tyra Biosciences (TYRA) | 2.0 | $19M | 1.4M | 13.85 | |
| Terns Pharmaceuticals (TERN) | 1.4 | $13M | 2.0M | 6.49 | |
| Spyre Therapeutics Com New (SYRE) | 0.9 | $8.1M | 378k | 21.52 |
